Cargando…

Tumour-specific antibodies of the IgA class in rats after the implantation of a syngeneic tumour in the gut.

Detalles Bibliográficos
Autores principales:	Gyure, L. A., Dean, C. J., Hall, J. G., Styles, J. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1980
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010269/ https://www.ncbi.nlm.nih.gov/pubmed/7387860

Ejemplares similares

The shedding of viable cells into the local lymph by tumours growing in the gut of rats.
por: Gyure, L. A., et al.
Publicado: (1985)

Immunity to a syngeneic sarcoma induced in rats by dendritic lymph cells exposed to the tumour either in vivo or in vitro.
por: Gyure, L. A., et al.
Publicado: (1987)

IgA EGFR antibodies mediate tumour killing in vivo
por: Boross, Peter, et al.
Publicado: (2013)

Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
por: Dean, C. J., et al.
Publicado: (1982)

Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection.
por: Mongini, C., et al.
Publicado: (1996)

Potentiation of tumour growth by endotoxin in serum from syngeneic tumour-bearing mice.
por: Kearney, R., et al.
Publicado: (1980)

Simultaneous detection of celiac disease-specific IgA antibodies and total IgA
por: Grossmann, Kai, et al.
Publicado: (2016)

Growth of Syngeneic Tumours in Unimmunized Newborn and Adult Hosts
por: Forni, G., et al.
Publicado: (1973)

Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
por: Forni, G., et al.
Publicado: (1974)

Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.
por: Orbach-Arbouys, S., et al.
Publicado: (1977)

Lymphoreticular response to a syngeneic rat tumour: gravimetric and histological studies.
por: Flannery, G. R., et al.
Publicado: (1975)

Immune Response to a Syngeneic Rat Tumour: Development of Regional Node Lymphocyte Anergy
por: Flannery, G. R., et al.
Publicado: (1973)

Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.
por: Chalmers, P. J., et al.
Publicado: (1976)

Further Observations on the Effect of C. parvum and Anti-Tumour Globulin on Syngeneically Transplanted Mouse Tumours
por: Woodruff, M. F. A., et al.
Publicado: (1972)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972)

Stimulation of syngeneic and allogeneic lymphoid cells by tumour cells in vitro.
por: Potter, M. R., et al.
Publicado: (1975)

Immunisation with ‘naïve’ syngeneic dendritic cells protects mice from tumour challenge
por: Grimshaw, M J, et al.
Publicado: (2008)

Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
por: Matthews, N., et al.
Publicado: (1976)

Effect of carrageenan on the non-specific resistance of mice to injected syngeneic tumour cells, alone or in mixtures.
por: Wu, R. L., et al.
Publicado: (1979)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours.
por: Eccles, S. A., et al.
Publicado: (1980)

Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells.
por: Ben-Efraim, S., et al.
Publicado: (1981)

Recombinant IgA Antibodies
por: Yoo, Esther M., et al.
Publicado: (2007)

Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
por: Hall, J. G., et al.
Publicado: (1979)

Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines
por: Lindner, D, et al.
Publicado: (2009)

Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy
por: Zhao, Yan-feng, et al.
Publicado: (2017)

IgA pemphigus showing IgA antibodies to desmoglein 1 and 3
por: Hegazy, Salama, et al.
Publicado: (2016)

Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.
por: James, K., et al.
Publicado: (1979)

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1976)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
por: Modjtahedi, H., et al.
Publicado: (1993)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine
por: Zhao, Ting, et al.
Publicado: (2020)

Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.
por: Peters, L. J.
Publicado: (1975)

Influence of Tumour Growth on the Evolution of Cytotoxic Lymphoid Cells in Rats Bearing a Spontaneously Metastasizing Syngeneic Fibrosarcoma
por: Currie, G. A., et al.
Publicado: (1973)

Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
por: Al-Rayahi, Izzat A. M., et al.
Publicado: (2021)

HAPTEN-SPECIFIC IgE ANTIBODY RESPONSES IN MICE : I. SECONDARY IgE RESPONSES IN IRRADIATED RECIPIENTS OF SYNGENEIC PRIMED SPLEEN CELLS
por: Hamaoka, Toshiyuki, et al.
Publicado: (1973)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

A serologically detected tumour-specific membrane antigen of murine lymphomas which is not the target for syngeneic graft rejection.
por: Davey, G. C., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_2nc9s9pd3mu2cgptg9qh0173p7